Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments
- 1st Edition - March 17, 2026
- Latest edition
- Editors: Tuan Anh Nguyen, Bhupendra G. Prajapati, Devesh U. Kapoor
- Language: English
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the bo… Read more
Description
Description
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance.
For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.
For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.
Key features
Key features
- Provides an in-depth foundation on nanovaccines and nanomedicines, detailing their mechanisms, roles, and applications in cancer treatment
- Addresses both the advantages and potential side effects of nanovaccines and nanomedicines
- Emphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings
Readership
Readership
Researchers, academics and post graduate students in the fields of oncology, pharmacology, nanotechnology, and biomedical engineering
Table of contents
Table of contents
Part 1: Fundamentals
1. Introduction to nanovaccine in cancer treatments
2. Introduction to nanomedicine in cancer treatments
3. Sensors for Cancer Detection
4. Current Perspectives of Nanomedicines (in Cancer Treatment)
5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)
Part 2: Advantage and Application of Nanovaccine and Nanomedicine
6. Advantage of cancer Nanomedicine
7. Advantage of Targeted Nanomedicine (in Cancer Treatment)
8. Advantage of nanovaccine (in cancer treatment)
9. Nanovaccines and Nanomedicines in cancer treatment: Current Landscape
Part 3: The Other Side of Nanovaccine and Nanomedicine
10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)
11. Side effect and toxicity of nanomedicine (in cancer treatment)
12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy
13. Side effects and toxicity of nanoparticles in cancer treatment
14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications
15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine
16. Nanotoxicity/nano-genotoxicity in cancer care
17. Toxicity evaluation and management for nanoparticles used in the cancer therapy
18. Nanoparticle Toxicity in Cancer Nanomedicine
Part 4: Challenge and Perspectives
19. Nano-medicines and Nano-vaccines Manufacturing
20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment
21. Ethics in Cancer Nanomedicine
22. Ethics and regulations in nanomedicine/nanovaccines
23. Regulating nanomedicine: challenges and opportunities
24. Safety Assessment for Nanomedicines and Nanovaccines
25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues
26. Future perspectives of nanovaccines and nanomedicines
1. Introduction to nanovaccine in cancer treatments
2. Introduction to nanomedicine in cancer treatments
3. Sensors for Cancer Detection
4. Current Perspectives of Nanomedicines (in Cancer Treatment)
5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)
Part 2: Advantage and Application of Nanovaccine and Nanomedicine
6. Advantage of cancer Nanomedicine
7. Advantage of Targeted Nanomedicine (in Cancer Treatment)
8. Advantage of nanovaccine (in cancer treatment)
9. Nanovaccines and Nanomedicines in cancer treatment: Current Landscape
Part 3: The Other Side of Nanovaccine and Nanomedicine
10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)
11. Side effect and toxicity of nanomedicine (in cancer treatment)
12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy
13. Side effects and toxicity of nanoparticles in cancer treatment
14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications
15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine
16. Nanotoxicity/nano-genotoxicity in cancer care
17. Toxicity evaluation and management for nanoparticles used in the cancer therapy
18. Nanoparticle Toxicity in Cancer Nanomedicine
Part 4: Challenge and Perspectives
19. Nano-medicines and Nano-vaccines Manufacturing
20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment
21. Ethics in Cancer Nanomedicine
22. Ethics and regulations in nanomedicine/nanovaccines
23. Regulating nanomedicine: challenges and opportunities
24. Safety Assessment for Nanomedicines and Nanovaccines
25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues
26. Future perspectives of nanovaccines and nanomedicines
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 25, 2026
- Language: English
About the editors
About the editors
TN
Tuan Anh Nguyen
Tuan Anh Nguyen is a Senior Principal Research Scientist at the Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam. He received a BS in physics from Hanoi University in 1992, a BS in economics from Hanoi National Economics University in 1997, and a PhD in chemistry from the Paris Diderot University, France, in 2003. He was a Visiting Scientist at Seoul National University, South Korea, in 2004, and the University of Wollongong, Australia, in 2005. He then worked as a Postdoctoral Research Associate and Research Scientist at Montana State University, United States in 2006-09. In 2012 he was appointed as the Head of the Microanalysis Department at the Institute for Tropical Technology. His research areas of interest include smart sensors, smart networks, smart hospitals, smart cities, complexiverse, and digital twins. He has edited more than 74 books for Elsevier, 12 books for CRC Press, 1 book for Springer, 1 book for RSC, and 2 books for IGI Global. He is the Editor-in-Chief of Kenkyu Journal of Nanotechnology & Nanoscience.
Affiliations and expertise
Senior Principal Research Scientist, Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, VietnamBP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, IndiaView book on ScienceDirect
View book on ScienceDirect
Read Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments on ScienceDirect